A pharmacodynamic model of the effects of controlled-onset extended-release verapamil on 24-hour ambulatory blood pressure

International Journal of Clinical Pharmacology and Therapeutics

Volumn 43, Issue 4, 2005, Pages 187-194

  Lima, J J ^a   Nhi Beasley, B ^c   Parker, R B ^b   Johnson, J A ^d  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF PHARMACY   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Ambulatory blood pressure; Circadian rhythm; Pharmacokinetic pharmacodynamic model; Verapamil

Indexed keywords

DRUG METABOLITE; VERAPAMIL;

AMBULATORY MONITORING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIOLOGICAL MODEL; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED RELEASE FORMULATION; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG METABOLISM; HEART RATE; HUMAN; HYPERTENSION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 17444417849     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP43187     Document Type: Article

References (18)

1. Bright GM, Veldhuis JD, Iranmanesh A, Baumann G, Maheshwari H, Lima J 1999 Appraisal of growth hormone (GH) secretion: evaluation of a composite pharmacokinetic model that discriminates multiple components of GH input. J Clin Endocrinol Metab 84: 3301-3308
2. Gabrielsson J, Weiner D 1997 Modelling strategies. In: Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. Swedish Pharmaceutical Press, Stockholm, pp 251-319
3. Gupta SK, Yih BM, Atkinson L, Longstreth J 1995 The effect of food, time of dosing, and body position on the pharmacokinetics and pharmacodynamics of verapamil and norverapamil. J Clin Pharmacol 35: 1083-1093
4. Hahn G, Spahn-Langguth H, Mohrke W, Mutchler E 1991 Enantiospecific assay for verapamil and norverapamil in plasma. Archiv de Pharmazie 324 (Abstract): 716
5. Halberg J, Halberg F, Leach CN 1984 Variability of human blood pressure with reference mostly to the non-chronobiologic literature. Chronobiologia 11: 205-216
6. Hempel G, Karlsson MO, de Alwis DP, Toublanc N, McNay J, Schaefer HG 1998 Population pharmacokinetic-pharmacodynamic modeling of moxonidine using 24-hour ambulatory blood pressure measurements. Clin Pharmacol Ther 64: 622-635
7. Kohara K, Hara-Nakamura N, Takada Y, Iwata T, Ochi T, Kukita H, Muneta S, Hiwada K 1996 Effect of alacepril on 24-hour blood pressure in elderly hypertensive patients. Int J Clin Pharmacol Ther 34: 380-383
8. Machnig T, Engels G, Schobel S, Gellert J, Bachmann K 1993 A new approach for evaluating circadian blood pressure levels and variability from 24 h ambulatory blood pressure profiles. Am J Hypertens 6: 248-252
9. Millar-Craig MW, Bishop CN, Raftery EB 1978 Circadian variation of blood-pressure. Lancet 1: 795-797
10. Muller JE, Tofler GH, Stone PH 1989 Circadian variation and triggers of onset of acute cardiovascular disease (see comments). Circulation 79: 733-743
11. Muneta S, Kohara K, Hiwada K 1999 Effects of benidipine hydrochloride on 24-hour blood pressure and blood pressure response to mental stress in elderly patients with essential hypertension. Int J Clin Pharmacol Ther 37: 141-147
12. Nelson W, Tong YL, Lee JK, Halberg F 1979 Methods for cosinor-rhythmometry. Chronobiologia 6: 305-323
13. Nguyen BNT, Parker RB, Noujedehi M, Sullivan JM, Johnson JA 2000 Effects of COER-verapamil on circadian pattern of blood pressure and forearm vascular resistance. J Clin Pharmacol 40: 1480-1487
14. Palatini P, Casiglia E, Graniero GR, Dorigatti F, Lotoro F, Vriz O, Pessina AC 1995 Diltiazem vs. nicardipine on ambulatory and exercise blood pressure and on peripheral hemodynamics. Int J Clin Pharmacol Ther 33: 38-42
15. Tominaga M, Tsuchihashi T, Kinoshita H, Kobayashi K, Ohya Y, Abe I, Takata Y, Fujishima M 1995 Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, pranidipine (OPC-13340). Int J Clin Pharmacol Ther 33: 277-280
16. Verdecchia P 2000 Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 35: 844-851
17. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C 1990 Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension (see comments). Circulation 81: 528-536
18. White WB, Mehrotra DV, Black HR, Fakouhi TD 1997 Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus non-dippers). COER-Verapamil Study Group. Am J Cardiol 80: 469-474